CTOs on the Move

Mada Medical Products

www.madamedical.com

 
Mada is a manufacturer of several hundred Medical, Dental, Podiatric and Veterinary products catering to the Home Healthcare and Institutional markets. Mada was incorporated in 1969, with Production and Corporate Offices located in Carlstadt, New Jersey
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Healthtech Services

Healthtech Services, Llc is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Columbus Regional Healthcare System

Columbus Regional Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Columbus Regional Healthcare System is based in Whiteville, NC. You can find more information on Columbus Regional Healthcare System at www.crhealthcare.org

Union Printers Home

Union Printers Home is a Colorado Springs, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Globespan Transcription

Globespan Transcription is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alternate Health

Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health`s industry-leading software systems provide the platform for the company`s diverse operations, including blockchain tax collection systems, hemp-derived CBD product distribution, extract manufacturing and patient management systems for specialty clinics across North America. Through Alternate Health`s subsidiary, Blaine Labs, the Company is a leader in cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health`s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders.